Gemykibivirus生物学特性的研究及感染小鼠动物模型的建立
结题报告
批准号:
32000125
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
秦建如
依托单位:
学科分类:
病毒学
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
秦建如
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
Gemykibivirus为Genomoviridae科最新命名的一个病毒属,属于单链环状DNA病毒,该病毒基因组小、变异迅速、重组率高,在多种动物和环境样本中被检测到。而相关前期研究结果显示该病毒可能与人肺炎和脑炎相关,并且其他研究也证明该病毒可能对人进行潜在感染,并会造成较为严重的相关疾病,但是目前,关于该病毒的病原特征尚不清楚。本项目将针对Gemykibivirus这一潜在的新型病原,研究它在人群中抗体阳性率并分析其与临床疾病之间的关联,进一步通过反向遗传学手段获得病毒毒株,探寻这一病毒的感染、复制能力,最后,建立该病毒的小鼠感染动物模型,评估该病毒对哺乳动物的致病性,从而全面解析Gemykibivirus流行病学特点以及生物学特性,为揭示该病毒与人类疾病的关系奠定基础,也为该病毒的流行传播风险评估提供理论支持。
英文摘要
Gemykibivirus, belongs to single-stranded DNA virus, is one of the most recently established genus in the family of Genomoviridae. Though small genome size, rapid mutation and high recombination rate, this virus had been discovered in various animal and environmental samples. The results of previous studies showed that this virus may be associated with human pneumonia and encephalitis, as other relevant studies have also proved. However, at present, the pathogenic characteristics of this virus are still unclear. In this study, the antibody positive rate of Gemykibivirus was calculated by ELISA, and the potential relationship with clinical diseases was demonstrated by improved viral metagenomics technique. Moreover, Gemykibivirus was rescued by reverse genetics for the assessment of infection and replication in different cells. Finally, a mammalian model of infection was established to evaluate the pathogenicity of this virus. The epidemiological and biological characteristics of Gemykibivirus were comprehensively analyzed, which laid a foundation for revealing the relationship between Gemykibivirus and human diseases, and also provided theoretical support for the risk assessment of epidemic transmission of this virus.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.3390/ijms23158661
发表时间:2022-08-04
期刊:International journal of molecular sciences
影响因子:5.6
作者:
通讯作者:
The transmembrane replacement H7N9-VLP vaccine displays high levels of protection in mice.
跨膜替换H7N9-VLP疫苗在小鼠中显示高水平的保护。
DOI:10.3389/fmicb.2022.1003714
发表时间:2022
期刊:FRONTIERS IN MICROBIOLOGY
影响因子:5.2
作者:Qin, Jianru;Hu, Bing;Song, Qiqi;Wang, Ruijuan;Zhang, Xiangfei;Yu, Yaqi;Wang, Jian-Hua
通讯作者:Wang, Jian-Hua
DOI:10.3390/cimb44070218
发表时间:2022-07-09
期刊:CURRENT ISSUES IN MOLECULAR BIOLOGY
影响因子:3.1
作者:Zhang, Chunyan;Zhao, Yabin;Yu, Mengli;Qin, Jianru;Ye, Bingyu;Wang, Qiwen
通讯作者:Wang, Qiwen
DOI:10.3389/fphar.2022.849545
发表时间:2022
期刊:FRONTIERS IN PHARMACOLOGY
影响因子:5.6
作者:Qin, Jianru;Lin, Jilei;Zhang, Xiangfei;Yuan, Shuhua;Zhang, Chiyu;Yin, Yong
通讯作者:Yin, Yong
国内基金
海外基金